A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Narrows Losses in 2019 – Business News From Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
13 Teva : Top 25 Pharma & BioPharma in 2018 - Contract Pharma
15. Teva Pharmaceutical Industries | FiercePharma
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
Teva down as it reports lower sales and profit for 2018
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug | BioSpace
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva launches generic EpiPen Jr. - Drug Delivery Business
18. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceutical Industries Stock (TEVA): Why The Price Fell Today
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Will Teva Stock Rebound After A 10% Fall In A Month?
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
Teva Announces New Brand Positioning and Visual Identity in North America
Teva Execs Topped TASE's High Earners List for 2018 | Ctech
Teva Pharmaceutical Industries: Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch, Health News, ET HealthWorld
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
